STRS Ohio’s Cogent Biosciences COGT Stock Holding History

STRS Ohio’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$627K	Sell	16,200 -1,700	-9%	-$59.5K	﹤0.01%	1036
2026 Q1	$689K	Sell	17,900 -12,600	-41%	-$465K	﹤0.01%	859
2025 Q4	$1.08M	Sell	30,500 -11,000	-27%	-$309K	﹤0.01%	680
2025 Q3	$596K	Buy	41,500 +35,500	+592%	+$421K	﹤0.01%	939
2025 Q2	$43.1K	Hold	6,000	–	–	﹤0.01%	2049
2025 Q1	$35.9K	Hold	6,000	–	–	﹤0.01%	1803
2024 Q4	$46.8K	Buy	+6,000	New	+$59.8K	﹤0.01%	1737
2021 Q4	–	Sell	-8,600	Closed	-$72K	–	2212
2021 Q3	$72K	Hold	8,600	–	–	﹤0.01%	1996
2021 Q2	$69K	Buy	+8,600	New	+$72.6K	﹤0.01%	2052
2019 Q2	–	Sell	-250	Closed	-$4K	–	2123
2019 Q1	$4K	Hold	250	–	–	﹤0.01%	2026
2018 Q4	$4K	Hold	250	–	–	﹤0.01%	2052
2018 Q3	$10K	Hold	250	–	–	﹤0.01%	2076
2018 Q2	$14K	Buy	+250	New	+$12K	﹤0.01%	2075

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

STRS Ohio's COGT Position: Q2 2026 in Review

STRS Ohio reduced its Cogent Biosciences (COGT) stake by 9.5% in Q2 2026, selling an estimated $59.5K and leaving 16,200 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

STRS Ohio first reported a position in COGT in Q2 2018 and has held it in 13 quarters since. The position peaked at $1.08M in Q4 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

STRS Ohio held 16,200 shares of Cogent Biosciences worth $627K as of Q2 2026.
STRS Ohio sold 1,700 Cogent Biosciences shares in Q2 2026, an estimated $59.5K.
Cogent Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1036 holding.
STRS Ohio first reported a position in Cogent Biosciences in Q2 2018 and has held it in 13 quarters since.
STRS Ohio's Cogent Biosciences position peaked at $1.08M in Q4 2025.
324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.